Medicamen Organics (NSE:MEDIORG) E10: ₹0.00 (As of Mar. 2026)


NSE:MEDIORG Medicamen Organics Ltd NSE:MEDIORG
32 GF Score
Price ₹23.80
! 11 Warning Signs
View Full Analysis

What is Medicamen Organics E10?

Medicamen Organics NSE:MEDIORG -4.99% 32 E10 is ₹0.00 as of Mar. 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 32/100. The stock has 11 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medicamen Organics's adjusted earnings per share data for the fiscal year that ended in Mar. 2026 was ₹-3.410. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.00 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-07), Medicamen Organics's current stock price is ₹ 23.80. Medicamen Organics's E10 for the fiscal year that ended in Mar. 2026 was ₹0.00. Medicamen Organics's Shiller PE Ratio of today is .


Medicamen Organics  (NSE:MEDIORG) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medicamen Organics E10 Related Terms


Medicamen Organics E10 Historical Data

* Premium members only.

The historical data trend for Medicamen Organics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics E10 Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Mar25 Mar26
E10 Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NSE:MEDIORG vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicamen Organics Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medicamen Organics's Shiller PE Ratio falls into.


NSE:MEDIORG
32GF Score
Medicamen Organics Ltd NSE:MEDIORG
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Organics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicamen Organics's adjusted earnings per share data for the fiscal year that ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-3.41/164.2724*164.2724
=-3.410

Current CPI (Mar. 2026) = 164.2724.

Medicamen Organics does not have a history long enough to calculate E10. Therefore GuruFocus does not calculate it.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹0.00 mean?
Medicamen Organics (NSE:MEDIORG) has a E10 of ₹0.00 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medicamen Organics and its competitors.
Is Medicamen Organics' E10 too high?
Medicamen Organics' current E10 is ₹0.00. Overall, Medicamen Organics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' E10 compare to ZTS and UTHR?
Medicamen Organics' E10 of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medicamen Organics and its competitors. Medicamen Organics's current E10 is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current E10 of ₹0.00. The current E10 is ₹0.00. Medicamen Organics' overall GF Score™ is 32/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current E10 is ₹0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicamen Organics Business Description

Address Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
32GF Score

Get the complete analysis for NSE:MEDIORG

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.80
Price